Elisa Pesce

No ORCID on file · 4 papers in corpus · active 2023-2025

Study types

  • other 3
  • review 1

Condition tags

  • mesh:D004715 1
  • endometriosis 1
  • dyspareunia 1
other 2025
First use of cord blood platelet-rich plasma in the treatment of vulvar lichen sclerosus: a preliminary study towards a randomized controlled trial
Blood transfusion = Trasfusione del sangue ·doi:10.2450/BloodTransfus.875

BACKGROUND: Although topical corticosteroids (TCS) represent first-line treatment for vulvar lichen sclerosus (VLS) and as such should be prescribed to all women at time of diagnosis, approximately 30% of patients do not experience complete…

other 2024
A Longitudinal Multiinstitutional Study of Vulvar Lichen Sclerosus: From Childhood to Perimenopause
Journal of lower genital tract disease ·doi:10.1097/LGT.0000000000000816

OBJECTIVE: The main outcome of this study was the evaluation of clinical characteristics, comorbidities, and therapeutic approaches in patients with vulvar lichen sclerosus (VLS) aged from childhood to perimenopause. Secondly, it was intend…

other 2024
Beyond vulvodynia: from a correct diagnosis to a multidisciplinary care program. A referral center experience
Archives of gynecology and obstetrics ·doi:10.1007/s00404-024-07496-0

BACKGROUND: Vulvodynia is a chronic pain condition without an identifiable cause. As such, it is a diagnosis of exclusion, and all other causes of vulvar pain should be excluded. Although a standard treatment for vulvodynia has not been est…

review 2023
Non-response to first-line hormonal treatment for symptomatic endometriosis: overcoming tunnel vision. A narrative review
BMC women's health ·doi:10.1186/s12905-023-02490-1

One-fourth to one-third of women with endometriosis receiving first-line hormonal treatment lacks an adequate response in terms of resolution of painful symptoms. This phenomenon has been ascribed to "progesterone resistance", an entity tha…